U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C14H21NOS
Molecular Weight 251.388
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ESPROQUIN

SMILES

CC[S+]([O-])CCCN1CCC2=CC=CC=C2C1

InChI

InChIKey=YKKQKMDOWYCXEX-UHFFFAOYSA-N
InChI=1S/C14H21NOS/c1-2-17(16)11-5-9-15-10-8-13-6-3-4-7-14(13)12-15/h3-4,6-7H,2,5,8-12H2,1H3

HIDE SMILES / InChI
Molecular Formula C14H21NOS
Molecular Weight 251.388
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Esproquine is a tetrahydroisoquinoline derivative. It exerts positive inotropic effect and increases arterial pressure.

Originator

Neisler Laboratories, Inc.
2

Approval Year

Unknown
149,124

PubMed

Sample Use Guides

In Vivo Use Guide
single oral doses of 100, 200, or 300 mg esproquine
Route of Administration: Oral
Substance Class Chemical
Record UNII
3JYK9XFM9K
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966